Wells Fargo
BNTX icon

Wells Fargo’s BioNTech BNTX Stock Holding History

Wells Fargo’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-15,000
Closed -$3.36M – 6978
2021
Q2 		$3.36M Buy
+15,000
New +$2.83M ﹤0.01% 3229
2021
Q1 		– Sell
-60,000
Closed -$1.54M – 6897
2020
Q4 		$1.54M Buy
+60,000
New +$5.89M ﹤0.01% 3679
2020
Q3 		– Sell
-20,000
Closed -$38K – 6343
2020
Q2 		$38K Buy
+20,000
New +$999K ﹤0.01% 5555

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo's BNTX Position: Q1 2026 in Review

Wells Fargo increased its BioNTech (BNTX) stake by 177% in Q1 2026, buying an estimated $1.04M and bringing the position to 15,813 shares worth $1.41M. The position accounts for ﹤0.01% of the portfolio, ranked #3530.

Wells Fargo first reported a position in BNTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $21.9M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • Wells Fargo held 15,813 shares of BioNTech worth $1.41M as of Q1 2026.
  • Wells Fargo bought 10,111 BioNTech shares in Q1 2026, an estimated $1.04M.
  • BioNTech made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3530 holding.
  • Wells Fargo first reported a position in BioNTech in Q1 2020 and has held it in 25 quarters since.
  • Wells Fargo's BioNTech position peaked at $21.9M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.